Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of the fiscal period ended Tuesday, September 30, 2025.
Reported quarterly profit margin; no daily interpolation. Q2 FY2025 (2025-09-30): 0.00%.
NET PROFIT MARGIN
N/A
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Psyence Biomedical Ltd.
Market Cap
$95475.00
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$109148.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$71053.00
Net Profit Margin
-22521.52%
TTM Avg
-14229.41%
3Y Avg
-9670.52%
5Y Avg
-6447.01%
Market Cap
$61172.00
Net Profit Margin
-17690.19%
TTM Avg
-9089.88%
3Y Avg
-5029.73%
5Y Avg
-25219.12%
Market Cap
$30562.00
Net Profit Margin
-55.47%
TTM Avg
-29.76%
3Y Avg
-34.66%
5Y Avg
-18.73%
Market Cap
$28787.00
Net Profit Margin
-44.25%
TTM Avg
-77.97%
3Y Avg
-46.13%
5Y Avg
-41.70%
Market Cap
$6102.00
Net Profit Margin
N/A
TTM Avg
99.68%
3Y Avg
52.40%
5Y Avg
41.92%
Market Cap
$246973.00
Net Profit Margin
-1422.78%
TTM Avg
-951.97%
3Y Avg
-568.57%
5Y Avg
-575.76%
Market Cap
$358320.00
Net Profit Margin
-40439.10%
TTM Avg
-68089.13%
3Y Avg
-51057.85%
5Y Avg
-34126.19%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Psyence Biomedical Ltd. (PBM) | $95475.00 | N/A | 0.00% | 0.00% | 0.00% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109148.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| PRF Technologies Ltd. (PRFX)vs › | $71053.00 | -22521.52% | -14229.41% | -9670.52% | -6447.01% |
| Akanda Corp. (AKAN)vs › | $61172.00 | -17690.19% | -9089.88% | -5029.73% | -25219.12% |
| Zhongchao Inc. (ZCMD)vs › | $30562.00 | -55.47% | -29.76% | -34.66% | -18.73% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $28787.00 | -44.25% | -77.97% | -46.13% | -41.70% |
| NewGenIvf Group Limited (NIVF)vs › | $6102.00 | N/A | 99.68% | 52.40% | 41.92% |
| SciSparc Ltd. (SPRC)vs › | $246973.00 | -1422.78% | -951.97% | -568.57% | -575.76% |
| Virax Biolabs Group Limited (VRAX)vs › | $358320.00 | -40439.10% | -68089.13% | -51057.85% | -34126.19% |
| Niki BioSolutions, Inc. (NIKI)vs › | $401484.00 | 0.00% | 0.00% | -352.76% | -376.69% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-09-30 | 0.00% |
| 2024-09-30 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
